Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIMMCov-study: Ciclesonide vs placebo in mild-to-moderate COVID-19
2020-002208-37Phase 2Terminated
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia comparing Ciclesonide arm with Placebo arm (2 arms). Started Jun 2020; status: terminated.
02
Drugs
ciclesonide
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on 2020-002208-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002208-37.